Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Stana

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 15, 2013
Studies of atomic diffusion in Ni-Pt solid solution by x-ray photon correlation spectroscopyMarkus Stana, Michael Leitner, Manuel Ross, et al.
Medical Physics|May 5, 2026
Prediction of VMAT gamma passing rates using 3D CNNs based on leaf position analysis and gradient class activation mapping for plan complexity evaluationJohannes Berchtold, Sara Vockner, Ivan Messner, et al.
Thoracic Cancer|February 15, 2021
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysisBrane Grambozov, Romana Wass, Markus Stana, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2023
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapyBrane Grambozov, Forough Kalantari, Mohsen Beheshti, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective AnalysisBrane Grambozov, Evelyn Nussdorfer, Julia Kaiser, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Carbon Monoxide Diffusing Capacity (DL<sub>CO</sub>) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage IIIMarkus Stana, Brane Grambozov, Christoph Gaisberger, et al.
Cancers|April 13, 2023
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL<sub>CO</sub> Correlate with Radiation Dosimetry and Pneumonitis RateMarkus Stana, Brane Grambozov, Josef Karner, et al.
Cancers|February 15, 2022
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLCBrane Grambozov, Markus Stana, Bernhard Kaiser, et al.
Genes|December 1, 2020
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast CancerBarbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Biomedicines|August 28, 2025
Delta Changes in [<sup>18</sup>F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation-ChemoimmunotherapyBrane Grambozov, Nazanin Zamani-Siahkali, Markus Stana, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 15, 2013
Studies of atomic diffusion in Ni-Pt solid solution by x-ray photon correlation spectroscopyMarkus Stana, Michael Leitner, Manuel Ross, et al.
Medical Physics|May 5, 2026
Prediction of VMAT gamma passing rates using 3D CNNs based on leaf position analysis and gradient class activation mapping for plan complexity evaluationJohannes Berchtold, Sara Vockner, Ivan Messner, et al.
Thoracic Cancer|February 15, 2021
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysisBrane Grambozov, Romana Wass, Markus Stana, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2023
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapyBrane Grambozov, Forough Kalantari, Mohsen Beheshti, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective AnalysisBrane Grambozov, Evelyn Nussdorfer, Julia Kaiser, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Carbon Monoxide Diffusing Capacity (DL<sub>CO</sub>) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage IIIMarkus Stana, Brane Grambozov, Christoph Gaisberger, et al.
Cancers|April 13, 2023
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL<sub>CO</sub> Correlate with Radiation Dosimetry and Pneumonitis RateMarkus Stana, Brane Grambozov, Josef Karner, et al.
Cancers|February 15, 2022
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLCBrane Grambozov, Markus Stana, Bernhard Kaiser, et al.
Genes|December 1, 2020
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast CancerBarbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Biomedicines|August 28, 2025
Delta Changes in [<sup>18</sup>F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation-ChemoimmunotherapyBrane Grambozov, Nazanin Zamani-Siahkali, Markus Stana, et al.
Pageof 2